Literature DB >> 3972669

Is cancer treatment toxicity accurately reported?

M B Parliament, C E Danjoux, T Clayton.   

Abstract

To assess current documentation of treatment-related toxicity, 46 out-patients attending the Ottawa Civic Hospital Cancer Clinic were randomly selected. Physician's charting of toxicities was compared to patient's perception of toxicity, as recorded on a brief questionnaire. As a group, patients reported significantly more toxicities than had been recorded by their physician. The greatest disparity was observed for the following categories: nausea, vomiting, alopecia, and decreased performance status. The best-documented toxicities were: skin and mucosal reactions, and urinary symptoms. To the question concerning their most bothersome symptoms, patients described nausea, vomiting, mucosal reaction, and decreased performance status as the most common. In 46% of cases, the physician's notes failed to identify the patient's worst symptom. From our study; toxicity is probably under-reported, and unrecognized by oncologists. A self-administered questionnaire appears to be a better way of accurately identifying and reporting treatment toxicities, when compared to the oncologist's evaluation, as recorded in the patient's permanent record.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3972669     DOI: 10.1016/0360-3016(85)90195-6

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

1.  Lifting symptom burden--how far off the ground are we?

Authors:  Mellar P Davis; Jordanka Kirkova
Journal:  Support Care Cancer       Date:  2008-02-07       Impact factor: 3.603

2.  Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993).

Authors:  Pamela J Atherton; Kelli N Burger; Charles L Loprinzi; Michelle A Neben Wittich; Robert C Miller; Aminah Jatoi; Jeff A Sloan
Journal:  Support Care Cancer       Date:  2011-09-16       Impact factor: 3.603

3.  Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Authors:  Deborah Watkins Bruner; Laura J Hanisch; Bryce B Reeve; Andy M Trotti; Deborah Schrag; Laura Sit; Tito R Mendoza; Lori Minasian; Ann O'Mara; Andrea M Denicoff; Julia H Rowland; Michael Montello; Cindy Geoghegan; Amy P Abernethy; Steven B Clauser; Kathleen Castro; Sandra A Mitchell; Laurie Burke; Ann Marie Trentacosti; Ethan M Basch
Journal:  Transl Behav Med       Date:  2011-03       Impact factor: 3.046

4.  Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4).

Authors:  Michelle A Neben-Wittich; Pamela J Atherton; David J Schwartz; Jeff A Sloan; Patricia C Griffin; Richard L Deming; Jon C Anders; Charles L Loprinzi; Kelli N Burger; James A Martenson; Robert C Miller
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-01       Impact factor: 7.038

5.  Patients' and doctors' perception of long-term morbidity in patients with testicular cancer clinical stage I. A descriptive pilot study.

Authors:  S D Fosså; C Moynihan; S Serbouti
Journal:  Support Care Cancer       Date:  1996-03       Impact factor: 3.603

6.  Identification of Uncontrolled Symptoms in Cancer Patients Using Natural Language Processing.

Authors:  Lisa DiMartino; Thomas Miano; Kathryn Wessell; Buck Bohac; Laura C Hanson
Journal:  J Pain Symptom Manage       Date:  2021-11-04       Impact factor: 3.612

Review 7.  Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.

Authors:  Deborah Watkins Bruner; Charlene J Bryan; Neil Aaronson; C Craig Blackmore; Michael Brundage; David Cella; Patricia A Ganz; Carolyn Gotay; Pamela S Hinds; Alice B Kornblith; Benjamin Movsas; Jeff Sloan; Lari Wenzel; Giles Whalen
Journal:  J Clin Oncol       Date:  2007-11-10       Impact factor: 44.544

8.  Utilizing Multidimensional Computer Adaptive Testing to Mitigate Burden With Patient Reported Outcomes.

Authors:  Michael Bass; Scott Morris; Richard Neapolitan
Journal:  AMIA Annu Symp Proc       Date:  2015-11-05

9.  Advancing the efficiency and efficacy of patient reported outcomes with multivariate computer adaptive testing.

Authors:  Scott Morris; Mike Bass; Mirinae Lee; Richard E Neapolitan
Journal:  J Am Med Inform Assoc       Date:  2017-09-01       Impact factor: 4.497

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.